Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Enhanced Aromatic Sequons Increase Oligosaccharyltransferase Glycosylation Efficiency and Glycan Homogeneity.

Murray AN, Chen W, Antonopoulos A, Hanson SR, Wiseman RL, Dell A, Haslam SM, Powers DL, Powers ET, Kelly JW.

Chem Biol. 2015 Aug 20;22(8):1052-62. doi: 10.1016/j.chembiol.2015.06.017. Epub 2015 Jul 16.

2.

Thrombotic responses of endothelial outgrowth cells to protein-coated surfaces.

Anderson DE, McKenna KA, Glynn JJ, Marzec U, Hanson SR, Hinds MT.

Cells Tissues Organs. 2014;199(4):238-48. doi: 10.1159/000368223. Epub 2015 Jan 16.

3.

Long-term outcome after spinal cord infarctions.

Hanson SR, Romi F, Rekand T, Naess H.

Acta Neurol Scand. 2015 Apr;131(4):253-7. doi: 10.1111/ane.12343. Epub 2014 Oct 27.

PMID:
25346212
4.

Immobilization of actively thromboresistant assemblies on sterile blood-contacting surfaces.

Qu Z, Krishnamurthy V, Haller CA, Dorr BM, Marzec UM, Hurst S, Hinds MT, Hanson SR, Liu DR, Chaikof EL.

Adv Healthc Mater. 2014 Jan;3(1):30-5. doi: 10.1002/adhm.201300110. Epub 2013 Jun 21.

5.

Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates.

Crosby JR, Marzec U, Revenko AS, Zhao C, Gao D, Matafonov A, Gailani D, MacLeod AR, Tucker EI, Gruber A, Hanson SR, Monia BP.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1670-8. doi: 10.1161/ATVBAHA.113.301282. Epub 2013 Apr 4. Erratum in: Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):e127. Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):e130.

6.

N-glycosylation of enhanced aromatic sequons to increase glycoprotein stability.

Price JL, Culyba EK, Chen W, Murray AN, Hanson SR, Wong CH, Powers ET, Kelly JW.

Biopolymers. 2012;98(3):195-211. doi: 10.1002/bip.22030. Epub 2012 Feb 3.

7.

Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.

Heeb MJ, Marzec U, Gruber A, Hanson SR.

Thromb Haemost. 2012 Apr;107(4):690-8. doi: 10.1160/TH11-10-0699. Epub 2012 Feb 28.

8.

A biologically active surface enzyme assembly that attenuates thrombus formation.

Qu Z, Muthukrishnan S, Urlam MK, Haller CA, Jordan SW, Kumar VA, Marzec UM, Elkasabi Y, Lahann J, Hanson SR, Chaikof EL.

Adv Funct Mater. 2011 Dec 20;21(24):4736-4743. Epub 2011 Sep 26.

9.

Fluid shear stress alters the hemostatic properties of endothelial outgrowth cells.

Ensley AE, Nerem RM, Anderson DE, Hanson SR, Hinds MT.

Tissue Eng Part A. 2012 Jan;18(1-2):127-36. doi: 10.1089/ten.TEA.2010.0290. Epub 2011 Sep 16.

10.

Enzymes in the synthesis of glycoconjugates.

Schmaltz RM, Hanson SR, Wong CH.

Chem Rev. 2011 Jul 13;111(7):4259-307. doi: 10.1021/cr200113w. Review. No abstract available.

PMID:
21749134
11.

Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.

Larsen K, Cheng C, Tempel D, Parker S, Yazdani S, den Dekker WK, Houtgraaf JH, de Jong R, Swager-ten Hoor S, Ligtenberg E, Hanson SR, Rowland S, Kolodgie F, Serruys PW, Virmani R, Duckers HJ.

Eur Heart J. 2012 Jan;33(1):120-8. doi: 10.1093/eurheartj/ehr196. Epub 2011 Jul 6.

12.

Evaluation of sulfatase-directed quinone methide traps for proteomics.

Lenger J, Schröder M, Ennemann EC, Müller B, Wong CH, Noll T, Dierks T, Hanson SR, Sewald N.

Bioorg Med Chem. 2012 Jan 15;20(2):622-7. doi: 10.1016/j.bmc.2011.04.044. Epub 2011 Apr 24.

13.

Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns.

Culyba EK, Price JL, Hanson SR, Dhar A, Wong CH, Gruebele M, Powers ET, Kelly JW.

Science. 2011 Feb 4;331(6017):571-5. doi: 10.1126/science.1198461. Erratum in: Science. 2012 Mar 2;335(6072):1042.

14.

Numerical investigation of the effects of channel geometry on platelet activation and blood damage.

Wu J, Yun BM, Fallon AM, Hanson SR, Aidun CK, Yoganathan AP.

Ann Biomed Eng. 2011 Feb;39(2):897-910. doi: 10.1007/s10439-010-0184-2. Epub 2010 Oct 26.

15.

Glucosamine-6-sulfamate analogues of heparan sulfate as inhibitors of endosulfatases.

Schelwies M, Brinson D, Otsuki S, Hong YH, Lotz MK, Wong CH, Hanson SR.

Chembiochem. 2010 Nov 22;11(17):2393-7. doi: 10.1002/cbic.201000401. No abstract available.

16.

Non-destructive label-free monitoring of collagen gel remodeling using optical coherence tomography.

Levitz D, Hinds MT, Ardeshiri A, Hanson SR, Jacques SL.

Biomaterials. 2010 Nov;31(32):8210-7. doi: 10.1016/j.biomaterials.2010.06.042. Epub 2010 Aug 13.

17.

A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.

Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, White-Adams TC, Smith SA, Hanson SR, McCarty OJ, Renné T, Gruber A, Gailani D.

Blood. 2010 Nov 11;116(19):3981-9. doi: 10.1182/blood-2010-02-270918. Epub 2010 Jul 15.

18.

Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates.

Tucker EI, Marzec UM, Berny MA, Hurst S, Bunting S, McCarty OJ, Gruber A, Hanson SR.

Sci Transl Med. 2010 Jun 23;2(37):37ra45. doi: 10.1126/scitranslmed.3000697.

19.

Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways.

Otsuki S, Hanson SR, Miyaki S, Grogan SP, Kinoshita M, Asahara H, Wong CH, Lotz MK.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10202-7. doi: 10.1073/pnas.0913897107. Epub 2010 May 17.

20.

Quantitative characterization of developing collagen gels using optical coherence tomography.

Levitz D, Hinds MT, Choudhury N, Tran NT, Hanson SR, Jacques SL.

J Biomed Opt. 2010 Mar-Apr;15(2):026019. doi: 10.1117/1.3377961.

21.

Cytoskeletal structure regulates endothelial cell immunogenicity independent of fluid shear stress.

Vartanian KB, Berny MA, McCarty OJ, Hanson SR, Hinds MT.

Am J Physiol Cell Physiol. 2010 Feb;298(2):C333-41. doi: 10.1152/ajpcell.00340.2009. Epub 2009 Nov 18.

22.

Site-specific incorporation of the mucin-type N-acetylgalactosamine-alpha-O-threonine into protein in Escherichia coli.

Xu R, Hanson SR, Zhang Z, Yang YY, Schultz PG, Wong CH.

J Am Chem Soc. 2009 Sep 30;131(38):13883. doi: 10.1021/ja906705a. No abstract available.

PMID:
19731911
23.

The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability.

Hanson SR, Culyba EK, Hsu TL, Wong CH, Kelly JW, Powers ET.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3131-6. doi: 10.1073/pnas.0810318105. Epub 2009 Feb 9.

24.

Distinct extracellular matrix microenvironments of progenitor and carotid endothelial cells.

Vartanian KB, Kirkpatrick SJ, McCarty OJ, Vu TQ, Hanson SR, Hinds MT.

J Biomed Mater Res A. 2009 Nov;91(2):528-39. doi: 10.1002/jbm.a.32225.

PMID:
18985765
25.

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.

Tucker EI, Marzec UM, White TC, Hurst S, Rugonyi S, McCarty OJ, Gailani D, Gruber A, Hanson SR.

Blood. 2009 Jan 22;113(4):936-44. doi: 10.1182/blood-2008-06-163675. Epub 2008 Oct 22.

26.

Interaction between thrombin mutant W215A/E217A and direct thrombin inhibitor.

Tanaka KA, Gruber A, Szlam F, Bush LA, Hanson SR, Di Cera E.

Blood Coagul Fibrinolysis. 2008 Jul;19(5):465-8. doi: 10.1097/MBC.0b013e328304e044. No abstract available.

27.

Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody.

Markway BD, McCarty OJ, Marzec UM, Courtman DW, Hanson SR, Hinds MT.

Tissue Eng Part C Methods. 2008 Jun;14(2):97-105. doi: 10.1089/ten.tec.2007.0300.

PMID:
18544026
28.

Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis.

Tucker EI, Gailani D, Hurst S, Cheng Q, Hanson SR, Gruber A.

J Infect Dis. 2008 Jul 15;198(2):271-4. doi: 10.1086/589514.

29.

Endothelial cell cytoskeletal alignment independent of fluid shear stress on micropatterned surfaces.

Vartanian KB, Kirkpatrick SJ, Hanson SR, Hinds MT.

Biochem Biophys Res Commun. 2008 Jul 11;371(4):787-92. doi: 10.1016/j.bbrc.2008.04.167. Epub 2008 May 8.

PMID:
18471992
30.

Potential of baboon endothelial progenitor cells for tissue engineered vascular grafts.

Hinds MT, Ma M, Tran N, Ensley AE, Kladakis SM, Vartanian KB, Markway BD, Nerem RM, Hanson SR.

J Biomed Mater Res A. 2008 Sep;86(3):804-12.

PMID:
18041726
31.

Procoagulant properties of flow fields in stenotic and expansive orifices.

Fallon AM, Dasi LP, Marzec UM, Hanson SR, Yoganathan AP.

Ann Biomed Eng. 2008 Jan;36(1):1-13. Epub 2007 Nov 6.

PMID:
17985244
32.

Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.

Lovely RS, Boshkov LK, Marzec UM, Hanson SR, Farrell DH.

Br J Haematol. 2007 Nov;139(3):494-503.

PMID:
17910639
33.

Thrombin formation in vitro in response to shear-induced activation of platelets.

Fallon AM, Marzec UM, Hanson SR, Yoganathan AP.

Thromb Res. 2007;121(3):397-406. Epub 2007 May 29.

PMID:
17532367
34.

Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes.

Hanson SR, Hsu TL, Weerapana E, Kishikawa K, Simon GM, Cravatt BF, Wong CH.

J Am Chem Soc. 2007 Jun 13;129(23):7266-7. Epub 2007 May 17. No abstract available.

35.

The leech product saratin is a potent inhibitor of platelet integrin alpha2beta1 and von Willebrand factor binding to collagen.

White TC, Berny MA, Robinson DK, Yin H, DeGrado WF, Hanson SR, McCarty OJ.

FEBS J. 2007 Mar;274(6):1481-91.

36.

Three dimensional optical angiography.

Wang RK, Jacques SL, Ma Z, Hurst S, Hanson SR, Gruber A.

Opt Express. 2007 Apr 2;15(7):4083-97.

PMID:
19532651
37.

Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.

Hsu TL, Hanson SR, Kishikawa K, Wang SK, Sawa M, Wong CH.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2614-9. Epub 2007 Feb 12.

38.

Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.

Gruber A, Marzec UM, Bush L, Di Cera E, Fernández JA, Berny MA, Tucker EI, McCarty OJ, Griffin JH, Hanson SR.

Blood. 2007 May 1;109(9):3733-40. Epub 2007 Jan 16.

39.

The effect of a recombinant elastin-mimetic coating of an ePTFE prosthesis on acute thrombogenicity in a baboon arteriovenous shunt.

Jordan SW, Haller CA, Sallach RE, Apkarian RP, Hanson SR, Chaikof EL.

Biomaterials. 2007 Feb;28(6):1191-7. Epub 2006 Nov 7.

PMID:
17087991
40.
41.

Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo.

Sawa M, Hsu TL, Itoh T, Sugiyama M, Hanson SR, Vogt PK, Wong CH.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12371-6. Epub 2006 Aug 8.

42.

Flow and thrombosis at orifices simulating mechanical heart valve leakage regions.

Fallon AM, Shah N, Marzec UM, Warnock JN, Yoganathan AP, Hanson SR.

J Biomech Eng. 2006 Feb;128(1):30-9.

PMID:
16532615
43.

Fabrication of a phospholipid membrane-mimetic film on the luminal surface of an ePTFE vascular graft.

Jordan SW, Faucher KM, Caves JM, Apkarian RP, Rele SS, Sun XL, Hanson SR, Chaikof EL.

Biomaterials. 2006 Jun;27(18):3473-81. Epub 2006 Mar 3.

PMID:
16516285
44.

Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates.

Gruber A, Carlsson S, Kotzé HF, Marzec U, Sarich TC, Hanson SR.

Thromb Res. 2007;119(1):121-7. Epub 2006 Jan 31.

PMID:
16448687
45.

Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates.

Gruber A, Fernández JA, Bush L, Marzec U, Griffin JH, Hanson SR, DI Cera E.

J Thromb Haemost. 2006 Feb;4(2):392-7.

46.

Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.

Young WB, Mordenti J, Torkelson S, Shrader WD, Kolesnikov A, Rai R, Liu L, Hu H, Leahy EM, Green MJ, Sprengeler PA, Katz BA, Yu C, Janc JW, Elrod KC, Marzec UM, Hanson SR.

Bioorg Med Chem Lett. 2006 Apr 1;16(7):2037-41. Epub 2006 Jan 18.

PMID:
16412633
47.

Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.

Tanaka KA, Fernández JA, Marzec UM, Kelly AB, Mohri M, Griffin JH, Hanson SR, Gruber A.

Br J Haematol. 2006 Jan;132(2):197-203.

PMID:
16398653
48.

A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo.

Olivero AG, Eigenbrot C, Goldsmith R, Robarge K, Artis DR, Flygare J, Rawson T, Sutherlin DP, Kadkhodayan S, Beresini M, Elliott LO, DeGuzman GG, Banner DW, Ultsch M, Marzec U, Hanson SR, Refino C, Bunting S, Kirchhofer D.

J Biol Chem. 2005 Mar 11;280(10):9160-9. Epub 2005 Jan 4.

49.
50.

In vivo platelet redistribution and acute transient thrombocytopenia after eptifibatide injection in baboons.

Tanaka KA, Katori N, Kelly AB, Kotze H, Marzec U, Hanson SR.

Thromb Res. 2005;115(1-2):79-87.

PMID:
15567457

Supplemental Content

Loading ...
Support Center